Möchten Sie immer auf dem neuesten Stand bleiben?

Washington, D.C., March 24, 2026 (GLOBE NEWSWIRE) -- The New Civil Liberties Alliance, on behalf of its clients Jill Hines and Dr. Aaron Kheriaty, has reached a settlement agreement and Consent...

Belleville, Illinois, March 24, 2026 (GLOBE NEWSWIRE) -- During Brain Injury Awareness Month, Allsup, the nation’s leading provider of Social Security Disability Insurance (SSDI) representation is...

TB therapeutics market grows to USD 3.95 Bn by 2035, driven by MDR/XDR cases, innovation, funding support, and rising demand across high-burden regions.

OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with...

PITTSBURGH, PA, March 23, 2026 (GLOBE NEWSWIRE) -- Today, Niche released its 2026 Best Places to Live in America rankings, highlighting notable shifts across the country, including seven new places...

Allschwil, 23. März 2026 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...

Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...

BUFFALO, NY, March 18, 2026 (GLOBE NEWSWIRE) -- Austin Air Systems, a U.S.-based manufacturer of medical-grade air purification systems, today announced the launch of the Austin Air Mold Solutions...

Based on the Strength of Unprecedented Results from the Positive Phase 1/2 Study in Adults Aged 50 and Older, Vaxcyte Advanced VAX-31 High Dose into Comprehensive Phase 3 Adult Program; Topline Data...

KANSAS CITY, Kan., March 18, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to...